The largest database of trusted experimental protocols

Crpmi 1640

Manufactured by Thermo Fisher Scientific
Sourced in United States

CRPMI-1640 is a cell culture medium designed for the in vitro cultivation of a variety of cell types, including human and animal cells. It provides the necessary nutrients and growth factors required for cell growth and proliferation. The formulation is based on the original RPMI-1640 medium, which is a widely used and well-established culture medium in the field of cell biology and biomedical research.

Automatically generated - may contain errors

5 protocols using crpmi 1640

1

Macrophage Differentiation and Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
α,α′-Trehalose 6,6′-glycolipids, AF-2 and TDB, were made up to 1 mM in CHCl3/MeOH (2/1, v/v), then diluted to 400 μM or 50 μM in isopropanol to give 8 or 1 nmol of glycolipid per 20 μL, respectively. The solutions were then added to 96-well plates (20 µL/well) and the solvent was evaporated within a sterile hood for 18 h.
Bone marrow cells were collected from the tibia and femur of C57BL/6 or Mincle−/− mice and cultured (250,000 cells/mL) in complete Roswell Park Memorial Institute medium [cRPMI-1640 (Gibco) with 10% heat inactivated fetal bovine serum (Gibco), 100 unit/mL penicillin-streptomycin (Gibco) and 2 mM Glutamax (Gibco)]. Macrophage differentiation was induced by 50 ng/mL GM-CSF (PeproTech) added to the cRPMI. Cells were incubated at 37 °C (5% CO2) for 8 days (cells fed on days 3 and 6). On day 8, the media was removed, the cells were lifted using Accutase (StemCell), counted and re-seeded in 96-well plates coated with ligands. Where indicated Ac-YVAD-cmk (40 μM, Sigma) or KCl (50 mM) [12 (link)] were added to the cells an hour before, or CY-09 (20 or 40 µM) was added 30 min before adding the cells to ligand-coated plate according to the manufacturer’s protocol. 100 ng/mL LPS (Sigma) or nigericin (10 μM, ChemImpex) were used as controls [29 (link)].
+ Open protocol
+ Expand
2

Culturing Human Myeloid Leukemia and Packaging Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human myeloid leukemia cell line (K562) was cultured in complete Roswell Park Memorial Institute Medium (cRPMI 1640) (Gibco). Packaging cells (293T/17) were cultured in complete Dulbecco's modified Eagle's medium (cDMEM) (Gibco). Culture media were supplemented with 10% fetal bovine serum (FBS) (Hyclone), penicillin (100 U/ml), and streptomycin (100 μg/ml). Cells were maintained in a humidified incubator at 37°C and 5% CO2. cDMEM media without antibiotics were used for further lentiviral production.
+ Open protocol
+ Expand
3

Isolation and Differentiation of PBMCs and Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously reported, PBMCs and human-derived macrophages (MDMs) were isolated or differentiated (37 (link), 38 (link)). Briefly, PBMCs were enriched from whole blood by density gradient using Histopaque-1077 (Sigma-Aldrich, UK). Cells were washed twice in PBS and resuspended in Complete Roswell Park Memorial Institute Medium (cRPMI-1640) culture medium (RPMI 1640 with 2 mM glutamine; Gibco, Thermo Fisher Scientific, USA), 10% human serum (Sigma-Aldrich, USA), 10 U/mL penicillin/streptomycin, and 10 mM HEPES (Thermo Fisher Scientific, the Netherlands). Monocytes (CD14+) were isolated from PBMCs by positive selection using magnetically labeled CD14 Microbeads (Miltenyi Biotec). The isolated monocytes were then resuspended in cRPMI medium with 20 ng/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, Miltenyi Biotec), and cells were seeded at a concentration of 1 × 106 cells/mL in 24-well and 48-well plates (Corning Inc., South Korea) for 7 days. The culture medium was refreshed on the fourth day of incubation. Before infection, the acquisition of macrophage morphology was confirmed by visualization in a BX61 microscope (Olympus).
+ Open protocol
+ Expand
4

Establishment of Podoplanin-Expressing MPM Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, we used four human MPM cell lines. NCI‐H290, ACC‐MESO‐1, and ACC‐MESO‐4 were provided by Dr. Yoshitaka Sekido (Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan).28 NCI‐H226 and Chinese hamster ovary (CHO) were purchased from ATCC (Rockville, MD, USA). NCI‐H290 cells were transfected with appropriate amounts of pcDNA3/human podoplanin or pcDNA3/mock plasmids, using Metafectene (Nippon Genetics, Tokyo, Japan), according to the manufacturer's instructions. Stable transfectants (NCI‐H290/PDPN and NCI‐H290/mock) were selected by culture in medium containing 0.5 mg/mL Geneticin (Invitrogen, Carlsbad, CA, USA). These cells were maintained in RPMI‐1640 medium supplemented with 10% FBS (CRPMI‐1640; Gibco, Grand Island, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin (Meiji Seika Kaisha, Tokyo, Japan) in 5% CO2 at 37°C.
+ Open protocol
+ Expand
5

Generating Bone-Marrow-Derived Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate bone-marrow-derived dendritic cells (BMDCs), intact-Res-treated DCs (intact-Res-DCs) and γ-Res-treated DCs (γ-Res-DCs), whole bone marrow cells from C57BL/6 mice were lysed of red blood cells (RBCs) using RBC lysing buffer (Sigma-Aldrich), and then, the lysed cells were maintained in 6-well plates (1 × 10 6 cells/ml; 2 mL/well) and cultured at 37 °C in the presence of 5% CO 2 , using complete-RPMI 1640 (c-RPMI 1640, GIBCO, Carlsbad, CA, USA) containing 10% FBS (GIBCO), 100 U/mL penicillin, 100 U/mL streptomycin, 20 ng/mL GM-CSF (JW CreaGene, Daegu, Korea) and 0.5 ng/mL IL-4 (JW CreaGene). On day three of the culture, 1 mL c-RPMI 1640 medium was added to each well of the BMDC differentiation plates, and 1 mL c-RPMI 1640 medium was added to each well of the intact-Res-DCs and γ-Res-DC differentiation plates along with γ-Res and intact-Res at a concentration of 15 and 50 μg/mL. On day six of the culture, the plate media were changed with 1 mL c-RPMI 1640 medium per well. On day eight of the culture, the cells were harvested and stained with fluorescein-conjugated CD11c mAb. Over 90% of the cells expressed CD11c.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!